- Home
- LOB vs VCEL Comparison
LOB vs VCEL Comparison
Compare LOB & VCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LOB
- VCEL
- Stock Information
- Founded
- LOB 2008
- VCEL 1989
- Country
- LOB United States
- VCEL United States
- Employees
- LOB N/A
- VCEL N/A
- Industry
- LOB Major Banks
- VCEL Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- LOB Finance
- VCEL Health Care
- Exchange
- LOB Nasdaq
- VCEL Nasdaq
- Market Cap
- LOB 1.7B
- VCEL 1.6B
- IPO Year
- LOB 2015
- VCEL 1997
- Fundamental
- Price
- LOB $33.43
- VCEL $35.30
- Analyst Decision
- LOB Buy
- VCEL Strong Buy
- Analyst Count
- LOB 4
- VCEL 6
- Target Price
- LOB $43.75
- VCEL $58.60
- AVG Volume (30 Days)
- LOB 225.5K
- VCEL 664.1K
- Earning Date
- LOB 10-22-2025
- VCEL 11-06-2025
- Dividend Yield
- LOB 0.36%
- VCEL N/A
- EPS Growth
- LOB N/A
- VCEL 2045.40
- EPS
- LOB 1.21
- VCEL 0.13
- Revenue
- LOB $406,003,000.00
- VCEL $249,119,000.00
- Revenue This Year
- LOB $43.85
- VCEL $18.35
- Revenue Next Year
- LOB $11.42
- VCEL $22.26
- P/E Ratio
- LOB $27.54
- VCEL $260.20
- Revenue Growth
- LOB N/A
- VCEL 16.13
- 52 Week Low
- LOB $22.68
- VCEL $29.24
- 52 Week High
- LOB $50.30
- VCEL $63.00
- Technical
- Relative Strength Index (RSI)
- LOB 37.44
- VCEL 56.91
- Support Level
- LOB $32.80
- VCEL $33.14
- Resistance Level
- LOB $37.00
- VCEL $35.76
- Average True Range (ATR)
- LOB 1.16
- VCEL 1.58
- MACD
- LOB -0.22
- VCEL 0.49
- Stochastic Oscillator
- LOB 13.67
- VCEL 88.57
About LOB Live Oak Bancshares Inc.
Live Oak Bancshares Inc operates as the bank holding company for the Live Oak Banking Company. The company specializes in lending and deposit-related services to small businesses nationwide. The company identifies and extends lending to credit-worthy borrowers both within specific industries, also called verticals, through expertise within those industries, and more broadly to select borrowers outside of those industries. A portion of the loans originated by the Bank are partially guaranteed by the Small Business Administration under the 7(a) Loan Program and the U.S. Department of Agriculture Rural Energy for America Program, Water and Environmental Program, Business and Industry and Community Facilities loan programs.
About VCEL Vericel Corporation
Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.